Stuart Jebb Email & Phone Number

Stuart Jebb is the Chief Revenue Officer at Glutagen, a biopharmaceutical company based in Melbourne, Australia. Glutagen are dedicated to developing and commercialising novel therapeutics for those with coeliac disease and gluten-related disorders. Glutagen's flagship product, GluteGuard (www.gluteguard.com.au) is the only product in the world clinically proven to protect against the symptoms of accidental gluten ingestion. Put simply, GluteGuard is a tablet taken before a meal which breaks down gluten into harmless fragments allowing it to pass through the digestive system without causing symptoms typically suffered by those with gluten sensitivities.Launched in Australia in October 2022, GluteGuard is sold by all leading Australian pharmacy groups and was awarded 2023 Outstanding & Innovative New Consumer Healthcare Product by Consumer Healthcare Products Australia.Following the early success of GluteGuard in Australia, Stuart is focused on growing GluteGuard's international distribution through partnerships and joint ventures with leading consumer healthcare companies to make GluteGuard available in key markets, including the United States, Canada, New Zealand, United Kingdom, Europe, and the Middle East.Prior to joining the Glutagen team Stuart worked as a lawyer predominately in Mergers & Acquisitions and Capital Markets advising a broad range of clients including multinational manufactures, ASX listed entities and private investment groups.